GERM CELL TUMOR
Clinical trials for GERM CELL TUMOR explained in plain language.
Never miss a new study
Get alerted when new GERM CELL TUMOR trials appear
Sign up with your email to follow new studies for GERM CELL TUMOR, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Engineered t cells take on stubborn germ cell tumors
Disease control CompletedThis study tested a new treatment for a rare type of testicular cancer called nonseminomatous germ cell tumors. Researchers took patients' own immune cells (T cells) and modified them to recognize and attack cancer cells that carry a protein called CD30. The goal was to see if th…
Matched conditions: GERM CELL TUMOR
Phase: PHASE2 • Sponsor: UNC Lineberger Comprehensive Cancer Center • Aim: Disease control
Last updated May 19, 2026 12:00 UTC
-
New drug combo shows promise for tough childhood cancer
Disease control CompletedThis study tested a new treatment for children with a rare and hard-to-treat cancer called yolk sac tumor that had come back or not responded to standard chemotherapy. The treatment combined the drug sirolimus with a three-drug chemotherapy regimen. The goal was to see if this co…
Matched conditions: GERM CELL TUMOR
Phase: PHASE2, PHASE3 • Sponsor: Shandong First Medical University • Aim: Disease control
Last updated May 18, 2026 12:03 UTC
-
New hope for kids with rare cancer: thalidomide combo shows promise
Disease control CompletedThis study tested a new treatment for children with a rare type of cancer called yolk sac tumor that had come back or stopped responding to standard chemotherapy. The treatment combined the drug thalidomide with three chemotherapy drugs. The goal was to see if this combination co…
Matched conditions: GERM CELL TUMOR
Phase: PHASE2 • Sponsor: Shandong First Medical University • Aim: Disease control
Last updated May 18, 2026 12:00 UTC
-
Engineered immune cells delivered directly to the brain show promise in kids with tough tumors
Disease control CompletedThis early-phase study tested a new treatment for children and young adults with brain tumors that have come back or not responded to standard therapy. The treatment uses the patient's own immune cells, which are modified in a lab to recognize and attack a protein called EGFR fou…
Matched conditions: GERM CELL TUMOR
Phase: PHASE1 • Sponsor: Seattle Children's Hospital • Aim: Disease control
Last updated May 14, 2026 12:03 UTC
-
New stem cell approach offers hope for kids with relapsed cancers
Disease control CompletedThis study tested a new type of stem cell transplant for children and young adults (ages 2-21) with cancers that came back or didn't respond to treatment. The approach uses a special cell filter to speed up immune recovery after transplant. The main goal was to see if the procedu…
Matched conditions: GERM CELL TUMOR
Phase: PHASE1 • Sponsor: St. Jude Children's Research Hospital • Aim: Disease control
Last updated May 08, 2026 12:03 UTC